{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:44:12Z","timestamp":1782996252279,"version":"3.54.5"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,2]]},"DOI":"10.1093\/rheumatology\/keac609","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T15:44:25Z","timestamp":1666367065000},"page":"e161-e163","source":"Crossref","is-referenced-by-count":3,"title":["Guillain\u2013Barr\u00e9 syndrome is associated with ixekizumab in a patient with pustular psoriasis"],"prefix":"10.1093","volume":"62","author":[{"given":"Haijun","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Panyu Central Hospital , Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhua","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University , Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Panyu Central Hospital , Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Panyu Central Hospital , Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lie","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University , Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"2023050208180122200_keac609-B1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"2023050208180122200_keac609-B2","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet"},{"key":"2023050208180122200_keac609-B3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00415-010-5836-5","article-title":"The role of cytokines in Guillain-Barr\u00e9 syndrome","volume":"258","author":"Lu","year":"2011","journal-title":"J Neurol"},{"key":"2023050208180122200_keac609-B4","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1093\/rheumatology\/keab186","article-title":"A case of multifocal motor neuropathy after initiation of ixekizumab for psoriatic arthopathy","volume":"60","author":"McKenna","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2023050208180122200_keac609-B5","doi-asserted-by":"crossref","first-page":"P2.451","DOI":"10.1212\/WNL.90.15_supplement.P2.451","article-title":"Ustekinumab related CIDP in a patient with psoriatic arthritis","volume":"90","author":"Osman","year":"2018","journal-title":"Neurology"},{"key":"2023050208180122200_keac609-B6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/14728222.2017.1258402","article-title":"Tumor necrosis factor-\u03b1 in Guillain-Barr\u00e9 syndrome, friend or foe?","volume":"21","author":"Wang","year":"2017","journal-title":"Expert Opin Ther Targets"},{"key":"2023050208180122200_keac609-B7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","article-title":"Th1\/Th2\/Th17\/Treg cytokines in Guillain-Barr\u00e9 syndrome and experimental autoimmune neuritis","volume":"24","author":"Zhang","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"2023050208180122200_keac609-B8","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10067-017-3573-1","article-title":"Is secukinumab a safe alternative treatment for ankylosing spondylitis with Guillain Barr\u00e9 syndrome after anti-TNF-\u03b1 treatment? Case report and literature review","volume":"36","author":"Psarelis","year":"2017","journal-title":"Clin Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac609\/46859662\/keac609.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/5\/e161\/50120912\/keac609.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/5\/e161\/50120912\/keac609.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T07:52:47Z","timestamp":1728201167000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/5\/e161\/6767639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":8,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,10,21]]},"published-print":{"date-parts":[[2023,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac609","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,5,1]]},"published":{"date-parts":[[2022,10,21]]}}}